Style | Citing Format |
---|---|
MLA | Khamseh A, et al.. "Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity." Scientific Reports, vol. 15, no. 1, 2025, pp. -. |
APA | Khamseh A, Farhadi A, Jalilvand S, Yarandi F, Izadimood N, Ghorbani S, Saadati H, Shirali E, Jazayeri SM, Sarvari J (2025). Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity. Scientific Reports, 15(1), -. |
Chicago | Khamseh A, Farhadi A, Jalilvand S, Yarandi F, Izadimood N, Ghorbani S, Saadati H, Shirali E, Jazayeri SM, Sarvari J. "Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity." Scientific Reports 15, no. 1 (2025): -. |
Harvard | Khamseh A et al. (2025) 'Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity', Scientific Reports, 15(1), pp. -. |
Vancouver | Khamseh A, Farhadi A, Jalilvand S, Yarandi F, Izadimood N, Ghorbani S, et al.. Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity. Scientific Reports. 2025;15(1):-. |
BibTex | @article{ author = {Khamseh A and Farhadi A and Jalilvand S and Yarandi F and Izadimood N and Ghorbani S and Saadati H and Shirali E and Jazayeri SM and Sarvari J}, title = {Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity}, journal = {Scientific Reports}, volume = {15}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Khamseh A AU - Farhadi A AU - Jalilvand S AU - Yarandi F AU - Izadimood N AU - Ghorbani S AU - Saadati H AU - Shirali E AU - Jazayeri SM AU - Sarvari J TI - Analysis of Hpv-16 Viral Load, Integration Status, and P16 Expression in Relation to Ebv Co-Infection and Cervical Lesion Severity JO - Scientific Reports VL - 15 IS - 1 SP - EP - PY - 2025 ER - |